A new study, funded by Alzheimer’s Society, has identified three existing medications that could be repurposed to treat or prevent Alzheimer’s disease.
Researchers are studying whether existing, safe medicines could be adapted to treat dementia. This is known as drug repurposing, and it offers fresh hope for finding effective dementia treatments sooner.
Donanemab has been licensed in the UK as a treatment for early-stage Alzheimer’s but is only available privately, not through the NHS. Here's what we know about this new Alzheimer's drug.
Donanemab has been licensed in the UK as a treatment for early-stage Alzheimer’s but is only available privately, not through the NHS. Here's what we know about this new Alzheimer's drug.